"This will be our second year, but it was really important for our family to be able to be there last year, so recently after his passing," said David Bianco. A.J. Bianco was born with a congenital ...

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has announced positive and sustained results from its Phase 2 trial of the investigational therapy infigratinib in children with achondroplasia. The trial, known ...

For Andrew Hanna, adapting to changing situations on stage teaches him how to adapt to the many challenges in life. The ...

The high school sports year has come to a close, but a La Costa Canyon High School freshman swimmer is reshaping what is ...

On June 4, 2024, BridgeBio issued a press release “announc[ing] sustained positive results from PROPEL 2, a Phase 2 trial of the investigational therapy infigratinib in children with achondroplasia, ...

Layla-Grace is a happy, determined and chatty little girl who loves music and playing outside. The 18-month-old has been ...

Mizuho Securities analyst Salim Syed assigned a Buy rating on BridgeBio Pharma (BBIO – Research Report) on June 4 and set a price target ...

Overview A type of bone growth disorder. Due to genetic mutations, the cartilage does not convert into a bone during fetal ...

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BridgeBio Pharma, Inc. ("BridgeBio" or "the Company") . Investors who purchased BridgeBio securities are ...

Today's biotech news update includes a dramatic vote on MDMA therapy, record drug shortages, bad(?) news for Biomarin, and a ...

(Exclusive) She also notes that babies with dwarfism or achondroplasia can have "larger than normal" heads. From a birthing perspective, Liz admits that carrying Leighton was "just more bearable ...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on BridgeBio Pharma (BBIO – Research Report), with ...